A Comparison of Short Interval vs. Routine Postpartum Visit on Contraceptive Initiation
NCT ID: NCT02769676
Last Updated: 2019-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2016-05-31
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Shortened Time Interval to Postpartum Visit in Improving Postpartum Attendance
NCT03165838
Early vs. Interval Postpartum IUD Insertion
NCT03462758
Early Postpartum Intrauterine Device (IUD) Placement
NCT01594476
Postpartum Family Planning Utilization and Associated Factors Among Women During First Year After Childbirth in Assiut
NCT03890705
Impact of Earlier Postpartum Contact on Postpartum Visit Compliance and Maternal Wellbeing
NCT04226807
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
3-week visit
Participants randomized to this arm will receive an additional visit at 3-weeks postpartum
3-week visit
The intervention will be an additional visit to the usual postpartum care provider at 3-weeks postpartum.
usual care
Participants randomized to this arm will receive usual postpartum care, including the standard timing for a postpartum visit.
usual care
Participants in the usual care arm will receive no additional interventions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3-week visit
The intervention will be an additional visit to the usual postpartum care provider at 3-weeks postpartum.
usual care
Participants in the usual care arm will receive no additional interventions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receiving postpartum care at resident clinic
Exclusion Criteria
* Abortion, stillbirth, or neonatal death
* Non-English speaking
* Unable to comply with follow-up
14 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Society of Family Planning
OTHER
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Caitlin Bernard, MD
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Washington University in St Louis
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Yonemoto N, Nagai S, Mori R. Schedules for home visits in the early postpartum period. Cochrane Database Syst Rev. 2021 Jul 21;7(7):CD009326. doi: 10.1002/14651858.CD009326.pub4.
Bernard C, Wan L, Peipert JF, Madden T. Comparison of an additional early visit to routine postpartum care on initiation of long-acting reversible contraception: A randomized trial. Contraception. 2018 Sep;98(3):223-227. doi: 10.1016/j.contraception.2018.05.010. Epub 2018 May 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201512058
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.